Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new ...

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

California is denying popular and effective weight loss drugs to poor people — likely to spite President Donald Trump, who has tried to make them cheaper. As a result, only those who can afford to pay ...

Doctors explain the differences between the Wegovy pill and injection in terms of efficacy, side effects, and more. They ...

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

Lilly’s momentum isn’t just about its successful clinical results, though. It’s also about the company’s constant iteration ...

Analysts are expecting a two-fold jump in the sale of GLP-1 units over the next three months due to the steep price cuts ...

Biocon Pharma, a subsidiary of Biocon Ltd, has secured approval from the US FDA for its generic Liraglutide injection (gVictoza), used in treating Type 2 Diabetes Mellitus.

By Matt Riesenbach, Director of Product Management, ECI Software Solutions Key takeaways: GLP-1 medications are accelerating ...

The drugmaker unveiled a new Zepbound delivery system as its main rival absorbed fresh clinical and stock-market blows. It’s ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...